Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MTA vs Biodentine in Primary Molars Pulpotomy and Indirect Pulp Cap
NCT04863222Phase 4Recruiting
- Sponsor
- Geisinger
- Start
- Nov 2021
- Primary completion
- Aug 2026
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (2 arms), sponsored by Geisinger. Primary endpoints: Rate of clinical success in pulpotomies and indirect pulp caps at 4 years and Rate of radiographic success in pulpotomies and indirect pulp caps at 4 years. Started Nov 2021; status: recruiting.
Beyond the preview
Go deeper on NCT04863222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04863222.